1. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J, 2008, 31(1): 143-178.
[2]
2. Song WJ, Kang MG, Chang YS, et al. Epidemiology of adult asthma in Asia : toward a better understanding. Asia Pac Allergy, 2014, 4(2): 75-85.
[3]
3. Jose BP, Camargos PA, Cruz Filho AA, et al. Diagnostic accuracy of respiratory diseases in primary health units. Rev Assoc Med Bras, 2014, 60(6): 599-612.
6. Fife BT, Pauken KE. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Ann N Y Acad Sci, 2011, 1217: 45-59.
[7]
7. Pita-López ML, Pera A, Solana R. Adaptive memory of human NK-like CD8+ T-cells to aging, and viral and tumor antigens. Front Immunol, 2016, 7: 616.
[8]
8. Jutz S, Leitner J, Schmetterer K, et al. Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: simultaneous measurement of NF-κB, NFAT and AP-1. J Immunol Methods, 2016, 430: 10-20.
[9]
9. Parry RV, Chemnitz JM, Frauwirth KA, et al. CTLA-4 and PD-1 receptors inhibit T cell activation by distinct mechanisms. Mol Cell Biol, 2005, 25(21): 9543-9553.
[10]
10. Zamani MR, Aslani S, Salmaninejad A, et al. PD-1/PD-L and autoimmunity: A growing relationship. Cell Immunol, 2016, 310: 27-41.
[11]
11. Lee SK, Rrgby RJ, Zotos D, et al. B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells. J Exp Med, 2011, 208(7): 1377-1388.
[12]
12. Keir ME, Butte MJ, Freeman GJ, et al. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol, 2008, 26: 677-704.
[13]
13. Iwanmura C, Shinoda K, Endo Y, et al. Regulation of memory CD4 T-cell pool size and function by natural killer T cells in vivo. Proc Natl Acad Sci USA, 2012, 109(42): 16992-16997.
[14]
14. Saenz SA, Noti M, Artis D. Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. Trends Immunol, 2010, 31(11): 407-413.
[15]
15. Alonso MN, Wong MT, Zhang AL, et al. TH1, TH2, and TH17 cell instruct monocytes to differentiate into specialized dendritic cell subsets. Blood, 2011, 118(12): 3311-3320.
[16]
16. Maldonado RA, Soriano MA, Perdomo LC, et al. Control of T helper cell differentiation through cytokine receptor inclusion in the immunological synapse. J Exp Med, 2009, 206(4): 877-892.
[17]
17. Kim Y, Lee S, Kim YS, et al. Regulation of Th1/Th2 cells in asthma development: a mathematical model . Math Biosci Eng, 2013, 10(4): 1095-1133.
[18]
18. Taube JM, Klein AP, Brahmer JR, et al. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti–PD-1 therapy. Clin Cancer Res, 2014, 20(19): 5064-5074.
[19]
19. Huang RY, Eppolito C, Lele S, et al. LAG3 and PD1co-inhibitory molecules collaborate to limit CD8+ T cellsignaling and dampen antitumor immunity in a murine ovarian cancer model. Oncotarget, 2015, 6(29): 27359-27377.
[20]
20. Nguyen LT, Ohashi PS. Clinical blockade of PD1 and LAG3--potential mechanisms of action. Nat Rev Immunol, 2015, 15(1): 45-56.
